|
US5583238A
(en)
|
1990-11-19 |
1996-12-10 |
G. D. Searle & Co. |
Method for making intermediates useful in synthesis of retroviral protease inhibitors
|
|
DE69334250D1
(de)
|
1992-12-29 |
2009-01-29 |
Abbott Lab |
Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
|
|
US5543417A
(en)
|
1994-10-21 |
1996-08-06 |
Merck & Co., Inc. |
Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
|
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
|
CA2246256A1
(en)
|
1996-02-13 |
1997-08-21 |
Akzo Nobel Nv |
Serine protease inhibitors
|
|
IL120310A
(en)
|
1996-03-01 |
2002-02-10 |
Akzo Nobel Nv |
Serine protease inhibitors and pharmaceuticals containing them
|
|
WO1997037997A1
(en)
|
1996-04-04 |
1997-10-16 |
Brystol-Myers Squibb Company |
Cephalosporin derivatives
|
|
DE19748470A1
(de)
|
1997-11-03 |
1999-05-06 |
Hoechst Schering Agrevo Gmbh |
Carbamoylphenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
US20050267148A1
(en)
|
1998-07-15 |
2005-12-01 |
Teijin Limited |
Benzimidazole derivative
|
|
CN1187337C
(zh)
|
1998-07-15 |
2005-02-02 |
帝人株式会社 |
硫代苯并咪唑衍生物
|
|
JP2003506457A
(ja)
|
1999-08-04 |
2003-02-18 |
アグロン・ファーマシュウティカルズ・インコーポレーテッド |
抗ピコルナウィルス化合物及び組成物、その医薬的使用、並びにその合成のための物質
|
|
PA8507801A1
(es)
|
1999-12-03 |
2002-08-26 |
Agouron Pharma |
Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
|
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
US7012066B2
(en)
|
2000-07-21 |
2006-03-14 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
US7842727B2
(en)
|
2001-03-27 |
2010-11-30 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
AR037938A1
(es)
|
2001-12-21 |
2004-12-22 |
Syngenta Participations Ag |
Derivados de avermectina b1 que tienen un substituyente de aminosulfoniloxilo en la posicion 4''
|
|
MXPA04007163A
(es)
|
2002-01-23 |
2004-10-29 |
Schering Corp |
Compuestos de prolina como inhibidores de la proteasa serina ns3 para utilizarse en el tratamiento de la infeccion por el virus de la hepatitis c.
|
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
|
DE60322857D1
(de)
|
2002-03-25 |
2008-09-25 |
Nippon Kayaku Kk |
Neues alpha-amino-n-(diaminophosphinyl)lactamderivat
|
|
MY133587A
(en)
|
2002-05-29 |
2007-11-30 |
Glaxo Group Ltd |
Aromatic sulfones and their medical use
|
|
TW200406386A
(en)
|
2002-06-07 |
2004-05-01 |
Novartis Ag |
Organic compounds
|
|
UA84404C2
(ru)
|
2002-06-12 |
2008-10-27 |
Байоджен Айдек Ма Инк. |
Способ лечения ишемического реперфузионного повреждения с помощью антагонистов рецептора аденозина
|
|
GB0220187D0
(en)
|
2002-08-30 |
2002-10-09 |
Novartis Ag |
Organic compounds
|
|
WO2004058717A1
(en)
|
2002-12-20 |
2004-07-15 |
X-Ceptor Therapeutics, Inc. |
Isoquinolinone derivatives and their use as therapeutic agents
|
|
US7078419B2
(en)
|
2003-03-10 |
2006-07-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
WO2004093860A1
(en)
|
2003-04-21 |
2004-11-04 |
Pfizer Inc. |
Inhibitors of sars related coronavirus proteinase
|
|
US20040235952A1
(en)
|
2003-05-05 |
2004-11-25 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase
|
|
SE0301320D0
(sv)
|
2003-05-06 |
2003-05-06 |
Astrazeneca Ab |
Positive modulators of nicotinic acetylcholine receptors
|
|
US7754188B2
(en)
|
2003-06-30 |
2010-07-13 |
Merck Sharp & Dohme Corp. |
Radiolabeled cannabinoid-1 receptor modulators
|
|
MXPA06002250A
(es)
|
2003-08-26 |
2006-05-17 |
Schering Corp |
Inhibidores peptidomimeticos novedosos de la serina proteasa ns3 del virus de la hepatitis c.
|
|
US20060014821A1
(en)
|
2003-08-27 |
2006-01-19 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of SARS 3C like protease
|
|
AU2004270251B2
(en)
|
2003-09-05 |
2011-03-31 |
The General Hospital Corporation |
Polyacetal drug conjugates as release system
|
|
KR20060118532A
(ko)
|
2003-12-11 |
2006-11-23 |
쉐링 코포레이션 |
Ｃ형 간염 바이러스 ｎｓ３／ｎｓ４ａ 세린 프로테아제의억제제
|
|
AU2004312547A1
(en)
|
2003-12-31 |
2005-07-21 |
Taigen Biotechnology |
Protease inhibitors
|
|
US7462594B2
(en)
|
2003-12-31 |
2008-12-09 |
Taigen Biotechnology Co., Ltd. |
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
|
|
JP2007522135A
(ja)
|
2004-01-30 |
2007-08-09 |
ザ ジョンズ ホプキンス ユニバーシティ |
ニトロキシル前駆化合物および使用方法
|
|
RU2006134002A
(ru)
|
2004-02-27 |
2008-04-10 |
Шеринг Корпорейшн (US) |
Новые соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
|
|
US7816326B2
(en)
|
2004-02-27 |
2010-10-19 |
Schering Corporation |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
|
|
CN1950393A
(zh)
|
2004-02-27 |
2007-04-18 |
先灵公司 |
丙型肝炎病毒ns3蛋白酶的抑制剂
|
|
US7173057B2
(en)
|
2004-02-27 |
2007-02-06 |
Schering Corporation |
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
|
|
RU2428428C9
(ru)
|
2004-02-27 |
2012-03-10 |
Шеринг Корпорейшн |
Серусодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
|
|
WO2005113580A1
(en)
|
2004-05-21 |
2005-12-01 |
Pfizer Inc. |
Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
|
CA2570694A1
(en)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
ATE459605T1
(de)
|
2004-09-03 |
2010-03-15 |
Syngenta Ltd |
Isoxazolinderivate und deren verwendung als herbizide
|
|
ATE520672T1
(de)
|
2004-09-30 |
2011-09-15 |
Tibotec Pharm Ltd |
Hiv-hemmende 5-carbo- oder heterozyklisch substituierte pyrimidine
|
|
US8575342B2
(en)
|
2004-09-30 |
2013-11-05 |
Tibotech Pharmaceuticals Ltd. |
HIV inhibiting 5-heterocyclyl pyrimidines
|
|
CN100363346C
(zh)
*
|
2004-10-22 |
2008-01-23 |
清华大学 |
冠状病毒主蛋白酶的小分子抑制剂、制备方法及其应用
|
|
BRPI0517272A
(pt)
|
2004-10-29 |
2008-10-07 |
Tibotec Pharm Ltd |
derivados de pirimidina bicìclicos de inibição de hiv
|
|
WO2006061714A2
(en)
|
2004-12-09 |
2006-06-15 |
Pfizer Inc. |
Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
|
GB2422831A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
|
GB2422829A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
|
JP2008533181A
(ja)
|
2005-04-14 |
2008-08-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
三環式アゾール誘導体、それらの製造及び医薬品としての使用
|
|
CA2603204A1
(en)
|
2005-04-14 |
2006-10-19 |
F. Hoffmann-La Roche Ag |
Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
|
|
US20060281689A1
(en)
|
2005-06-02 |
2006-12-14 |
Schering Corporation |
Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
|
|
WO2006130552A2
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods of treating hepatitis c virus
|
|
KR20080031281A
(ko)
|
2005-06-16 |
2008-04-08 |
노파르티스 아게 |
락탐을 함유하는 ｈｃｖ 억제제
|
|
JP2009510157A
(ja)
|
2005-10-03 |
2009-03-12 |
ファイザー・プロダクツ・インク |
Ｈｉｖインテグラーゼ酵素の阻害剤
|
|
WO2007058832A2
(en)
|
2005-11-12 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
|
|
DE102005055354A1
(de)
|
2005-11-21 |
2007-10-31 |
Merck Patent Gmbh |
Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
|
|
WO2007068465A1
(en)
|
2005-12-15 |
2007-06-21 |
F. Hoffmann-La Roche Ag |
Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
|
|
DE102006012251A1
(de)
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln
|
|
CA2652307A1
(en)
|
2006-04-10 |
2007-10-18 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
|
TW200815351A
(en)
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
|
WO2008037266A1
(en)
|
2006-09-25 |
2008-04-03 |
Universite Libre De Bruxelles |
Inhibitors of conventional protein kinase c isozymes and use thereof for treating inflammatory diseases
|
|
US20100093738A1
(en)
|
2006-10-06 |
2010-04-15 |
Basf Se |
Fungicidal Compounds and Fungicidal Compositions
|
|
US20090137549A1
(en)
|
2006-11-09 |
2009-05-28 |
Paul John Edward |
Novel compounds useful for the treatment of degenerative & inflamatory diseases
|
|
AU2007338410B2
(en)
|
2006-12-27 |
2012-08-16 |
Sanofi-Aventis |
Cycloalkylamine substituted isoquinoline derivatives
|
|
CN101595094B
(zh)
|
2006-12-27 |
2013-02-20 |
塞诺菲-安万特股份有限公司 |
环烷基胺取代的异喹诺酮衍生物
|
|
WO2008104994A2
(en)
|
2007-02-28 |
2008-09-04 |
Advinus Therapeutics Private Limited |
2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
|
|
JP2008260716A
(ja)
|
2007-04-12 |
2008-10-30 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物及びそれを含有する有害節足動物防除剤
|
|
JP2008280339A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物及びそれを含有する有害節足動物防除剤
|
|
KR20100031578A
(ko)
|
2007-05-24 |
2010-03-23 |
메모리 파마슈티칼스 코포레이션 |
5-ｈｔ6 수용체 친화성을 갖는 4'-치환된 화합물
|
|
MX2010005033A
(es)
|
2007-11-06 |
2010-05-27 |
Du Pont |
Aminas heterociclicas fungicidas.
|
|
US9446995B2
(en)
|
2012-05-21 |
2016-09-20 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
US10189803B2
(en)
|
2008-02-22 |
2019-01-29 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
GB0808953D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
substituted quinazolines
|
|
GB0808951D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
GB0808952D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
GB0808967D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substitute quinazolines
|
|
GB0808950D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
GB0808947D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
ES2533788T3
(es)
|
2008-05-30 |
2015-04-14 |
Genentech, Inc. |
Compuestos inhibidores de PI3K de tipo purina y métodos de uso
|
|
US8440827B2
(en)
|
2008-07-31 |
2013-05-14 |
Duke University |
Photolabile caged transition metal complexes and methods of using the same
|
|
WO2010039982A1
(en)
|
2008-10-01 |
2010-04-08 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
US8497269B2
(en)
|
2008-10-10 |
2013-07-30 |
Amgen Inc. |
Phthalazine compounds as p38 map kinase modulators and methods of use thereof
|
|
US8772481B2
(en)
|
2008-10-10 |
2014-07-08 |
Amgen Inc. |
Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof
|
|
JP5819730B2
(ja)
|
2008-12-22 |
2015-11-24 |
ケモセントリックス，インコーポレイティド |
Ｃ５ａＲアンタゴニスト
|
|
JP2012521429A
(ja)
|
2009-03-23 |
2012-09-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
疼痛治療用のｐ２ｘ３受容体アンタゴニスト
|
|
WO2010138685A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
WO2010138659A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating brain tumors
|
|
WO2010138695A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
WO2010138652A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating kaposi sarcoma
|
|
WO2010138706A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating breast cancer
|
|
US9221765B2
(en)
|
2009-06-10 |
2015-12-29 |
North Carolina State University |
Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives
|
|
WO2011003932A2
(de)
|
2009-07-10 |
2011-01-13 |
Basf Se |
Verfahren zur direktaminierung von kohlenwasserstoffen zu aminokohlenwasserstoffen mit elektrochemischer abtrennung von wasserstoff
|
|
KR20120051022A
(ko)
|
2009-07-21 |
2012-05-21 |
길리애드 사이언시즈, 인코포레이티드 |
플라비비리데 바이러스의억제제
|
|
JP2013501003A
(ja)
|
2009-07-31 |
2013-01-10 |
バイオクライスト ファーマシューティカルズ， インコーポレイテッド |
ヤヌスキナーゼ阻害剤としてのピロロ［１，２−ｂ］ピリダジン誘導体
|
|
JP2011057661A
(ja)
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
|
TW201124078A
(en)
|
2009-12-22 |
2011-07-16 |
Du Pont |
Fungicidal 2-(bicyclic aryloxy) carboxamides
|
|
TWI491609B
(zh)
|
2010-01-15 |
2015-07-11 |
Gilead Sciences Inc |
黃熱病毒科（Ｆｌａｖｉｖｉｒｉｄａｅ）病毒之抑制劑類
|
|
EA201290575A1
(ru)
|
2010-01-15 |
2013-01-30 |
Джилид Сайэнс, Инк. |
Ингибиторы вирусов flaviviridae
|
|
US20120329704A1
(en)
|
2010-02-25 |
2012-12-27 |
Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patieentenzorg |
Process for the preparation of substituted prolyl peptides and similar peptidomimetics
|
|
WO2011132048A1
(en)
|
2010-04-19 |
2011-10-27 |
Glenmark Pharmaceutical S.A. |
Heteroaryl compounds as pde10a inhibitors
|
|
WO2011133659A2
(en)
|
2010-04-20 |
2011-10-27 |
Emory University |
Inhibitors of hif and angiogenesis
|
|
WO2011146748A1
(en)
|
2010-05-21 |
2011-11-24 |
New York University |
Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
|
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
BR112013005223A2
(pt)
|
2010-09-03 |
2016-05-03 |
Bayer Ip Gmbh |
"pirimidinonas e dihidropirimidinonas fusionadas substituídas."
|
|
AU2011320651A1
(en)
|
2010-10-29 |
2013-05-02 |
Merck Canada Inc. |
HIV integrase inhibitors
|
|
WO2012058531A2
(en)
|
2010-10-29 |
2012-05-03 |
North Carolina State University |
Modulation of response regulators by imidazole derivatives
|
|
WO2012087372A1
(en)
|
2010-12-22 |
2012-06-28 |
E. I. Du Pont De Nemours And Company |
Fungicidal 2-(bicyclic aryloxy)carboxamides
|
|
WO2012125668A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
CA2833887A1
(en)
|
2011-05-04 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Drug substances, pharmaceutical compositions and methods for preparing the same
|
|
CA2833507A1
(en)
|
2011-06-07 |
2012-12-13 |
Dainippon Sumitomo Pharma Co., Ltd. |
Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
CN102838523A
(zh)
|
2011-06-23 |
2012-12-26 |
南开大学 |
抗肠病毒71(ev71)戊内酰胺类化合物及其制备方法和用途
|
|
JP6121658B2
(ja)
|
2011-06-29 |
2017-04-26 |
大塚製薬株式会社 |
治療用化合物、及び関連する使用の方法
|
|
EP2731953A1
(en)
|
2011-07-15 |
2014-05-21 |
Abbvie Inc. |
Tricyclic inhibitors of kinases useful for the treatment of proliferative diseases
|
|
CN103732567A
(zh)
|
2011-08-22 |
2014-04-16 |
先正达参股股份有限公司 |
作为杀虫化合物的二氢呋喃衍生物
|
|
CA2850003C
(en)
|
2011-09-27 |
2020-01-07 |
Kansas State University Research Foundation |
Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
|
|
CN103130710B
(zh)
|
2011-11-29 |
2015-12-16 |
南开大学 |
抗肠病毒71(ev71)己内酰胺醛类化合物及其制备方法和用途
|
|
CN103145608B
(zh)
|
2011-12-07 |
2015-09-02 |
南开大学 |
抗肠病毒71(ev71)己内酰胺类化合物及其制备方法和用途
|
|
US9643974B2
(en)
|
2011-12-12 |
2017-05-09 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
|
US9453014B2
(en)
|
2011-12-22 |
2016-09-27 |
Connexios Life Sciences Pvt. Ltd. |
Cyclic amide derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase and uses thereof
|
|
SG11201402765TA
(en)
|
2011-12-30 |
2014-06-27 |
Hanmi Pharm Ind Co Ltd |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
|
|
US20150080381A1
(en)
|
2012-04-12 |
2015-03-19 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
|
CN104350039B
(zh)
|
2012-04-20 |
2017-10-03 |
组合化学工业株式会社 |
烷基苯基硫醚衍生物及有害生物防除剂
|
|
CA2872147A1
(en)
|
2012-05-02 |
2013-11-07 |
Kansas State University Research Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses
|
|
WO2013181135A1
(en)
|
2012-05-31 |
2013-12-05 |
Emory University |
Quinazoline derivatives, compositions, and uses related thereto
|
|
US10314816B2
(en)
|
2012-06-08 |
2019-06-11 |
Wisconsin Alumni Research Foundation |
Antimicrobial compounds, compositions and methods of use thereof
|
|
KR20150028999A
(ko)
|
2012-06-27 |
2015-03-17 |
에프. 호프만-라 로슈 아게 |
5-아자인다졸 화합물 및 이의 사용 방법
|
|
EP2733143A1
(en)
|
2012-11-14 |
2014-05-21 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma receptors ligands
|
|
WO2014078214A1
(en)
|
2012-11-15 |
2014-05-22 |
Merck Sharp & Dohme Corp. |
Azetidine benzimidazoles as pde10 inhibitors
|
|
JP2014133739A
(ja)
|
2012-12-12 |
2014-07-24 |
Dainippon Sumitomo Pharma Co Ltd |
インダゾール誘導体またはピロロピリジン誘導体からなる医薬
|
|
ES2684776T3
(es)
|
2013-01-18 |
2018-10-04 |
Bristol-Myers Squibb Company |
Ftalazinonas e isoquinolinonas como inhibidores de ROCK
|
|
WO2014172871A1
(en)
|
2013-04-25 |
2014-10-30 |
Syngenta Participations Ag |
Dihydrobenzofuran derivatives as insecticidal compounds
|
|
TWI646092B
(zh)
|
2013-08-26 |
2019-01-01 |
拜耳作物科學股份有限公司 |
具有殺蟲活性之化合物
|
|
WO2015036059A1
(en)
|
2013-09-16 |
2015-03-19 |
Basf Se |
Fungicidal pyrimidine compounds
|
|
CA2923101A1
(en)
|
2013-09-16 |
2015-03-19 |
Basf Se |
Fungicidal pyrimidine compounds
|
|
AU2014331111B2
(en)
|
2013-10-04 |
2018-05-31 |
Bayer Cropscience Aktiencesellschaft |
Use of substituted dihydro-oxindolyl sulfonamides, or the salts thereof, for increasing the stress tolerance of plants
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
JP5542237B1
(ja)
|
2013-11-28 |
2014-07-09 |
新日鉄住金エンジニアリング株式会社 |
高炉ガス乾式集塵設備のガス温度調節方法および高炉ガス乾式集塵設備
|
|
WO2015104254A1
(en)
|
2014-01-09 |
2015-07-16 |
Bayer Pharma Aktiengesellschaft |
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
|
|
EP3096751B1
(en)
|
2014-01-22 |
2021-01-06 |
Nabriva Therapeutics GmbH |
12-epi-pleuromutilins
|
|
NO2699580T3
(enExample)
|
2014-01-24 |
2018-02-24 |
|
|
|
JP6295702B2
(ja)
|
2014-02-14 |
2018-03-20 |
東洋インキＳｃホールディングス株式会社 |
反応性単量体、およびそれを用いた重合性組成物
|
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
|
JP6577958B2
(ja)
|
2014-04-11 |
2019-09-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
スピロ［３Ｈ−インドール−３，２’−ピロリジン］−２（１Ｈ）−オン誘導体およびＭＤＭ２−ｐ５３阻害剤としてのそれらの使用
|
|
CN105037367A
(zh)
|
2014-04-18 |
2015-11-11 |
四川海思科制药有限公司 |
氨基六元环类衍生物及其在医药上的应用
|
|
US9884876B2
(en)
|
2014-05-09 |
2018-02-06 |
Kineta, Inc. |
Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
|
|
DK3154957T3
(da)
|
2014-06-16 |
2020-02-17 |
Fundacion Para La Investig Medica Aplicada |
Hidtil ukendte forbindelser som dobbelte inhibitorer af histonmethyltransferaser og dna-methyltransferaser
|
|
EP2957561A1
(en)
|
2014-06-18 |
2015-12-23 |
Université Paris 6 Pierre et Marie Curie UPMC |
Novel fluoroquinolones and use thereof to treat bacterial infections
|
|
US9873680B2
(en)
|
2014-08-29 |
2018-01-23 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
WO2016050921A1
(en)
|
2014-10-02 |
2016-04-07 |
F. Hoffmann-La Roche Ag |
Pyrazole carboxamide compounds for use in the treament of disorders mediated by bruton's tyrosine kinase (btk)
|
|
CN105566321B
(zh)
|
2014-10-29 |
2020-04-21 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
|
JP6695875B2
(ja)
|
2014-11-20 |
2020-05-20 |
カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ |
抗がん剤としての新規な１，３，５−トリアジン系ｐｉ３ｋ阻害剤及びその製造方法
|
|
JP6858712B2
(ja)
|
2015-01-30 |
2021-04-14 |
リーバー インスティテュート フォー ブレイン ディベロップメントＬｉｅｂｅｒ Ｉｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂｒａｉｎ Ｄｅｖｅｌｏｐｍｅｎｔ |
Ｃｏｍｔ阻害方法及び組成物
|
|
GB201501870D0
(en)
|
2015-02-04 |
2015-03-18 |
Cancer Rec Tech Ltd |
Autotaxin inhibitors
|
|
GB201502045D0
(en)
|
2015-02-06 |
2015-03-25 |
Ocado Innovation Ltd |
Device and method for purchasing goods and services
|
|
US9409872B1
(en)
|
2015-02-16 |
2016-08-09 |
Mark Quang Nguyen |
Fumarate compounds, pharmaceutical compositions thereof, and methods of use
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
EP3308562B1
(en)
|
2015-06-15 |
2020-12-09 |
ARRIS Enterprises LLC |
Operator formed network consortiums
|
|
GB2548542A
(en)
|
2015-06-16 |
2017-09-27 |
Redx Pharma Plc |
Compounds
|
|
FR3037955B1
(fr)
|
2015-06-25 |
2017-08-18 |
Univ Nantes |
Ligands polydentates et complexes metalliques
|
|
HK1246781A1
(zh)
|
2015-07-30 |
2018-09-14 |
美迪维尔公司 |
呼吸道合胞病毒抑制剂
|
|
HUE054985T2
(hu)
|
2015-10-09 |
2021-11-29 |
Boehringer Ingelheim Int |
Spiro[3H-indol-3,2'-pirrolidin]-2(1H)-on vegyületek és számrazékok, mint MDM2-P53 inhibitorok
|
|
CN110072864B
(zh)
|
2015-12-24 |
2022-05-27 |
基因泰克公司 |
Tdo2抑制剂
|
|
CN106928206B
(zh)
|
2015-12-31 |
2022-02-18 |
中国科学院上海药物研究所 |
醛基类化合物及其制法和用途
|
|
JP6806413B2
(ja)
|
2016-02-03 |
2021-01-06 |
塩野義製薬株式会社 |
多環性ピリドン誘導体およびそのプロドラッグ
|
|
WO2017155816A1
(en)
|
2016-03-09 |
2017-09-14 |
Merck Sharp & Dohme Corp. |
Quinazoline compounds useful as m1 receptor positive allosteric modulators
|
|
WO2017165311A1
(en)
|
2016-03-21 |
2017-09-28 |
Perlstein Lab Pbc |
Fused heterocyclic organic compounds and uses thereof
|
|
US9975885B2
(en)
|
2016-04-28 |
2018-05-22 |
Purdue Research Foundation |
Broad-spectrum non-covalent coronavirus protease inhibitors
|
|
TW201808888A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808903A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TWI920577B
(zh)
|
2016-05-05 |
2026-04-01 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
US11021513B2
(en)
|
2016-05-13 |
2021-06-01 |
Emory University |
Peptidomimetics for the treatment of norovirus infection
|
|
CN107459511B
(zh)
|
2016-06-02 |
2020-05-29 |
南开大学 |
抗肠病毒71(ev71)4-亚氨基恶唑烷-2-酮类化合物及其制备方法和用途
|
|
US20170355708A1
(en)
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
US11013779B2
(en)
|
2016-06-20 |
2021-05-25 |
Kansas State University Research Foundation |
Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses
|
|
DK3481826T3
(da)
|
2016-07-08 |
2022-01-10 |
Rigel Pharmaceuticals Inc |
Tyrosinkinaseinhibitorer
|
|
WO2018015818A2
(en)
|
2016-07-15 |
2018-01-25 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
WO2018023054A1
(en)
|
2016-07-28 |
2018-02-01 |
Kansas State University Research Foundation |
Protease transition state inhibitor prodrugs
|
|
UY37381A
(es)
|
2016-08-30 |
2018-03-23 |
Glaxosmithkline Ip No 2 Ltd |
Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos
|
|
CN108069984B
(zh)
|
2016-11-18 |
2021-02-05 |
沈阳中化农药化工研发有限公司 |
含嘧啶并环的取代五元杂环类化合物及其制备方法和用途
|
|
WO2018108627A1
(de)
|
2016-12-12 |
2018-06-21 |
Bayer Cropscience Aktiengesellschaft |
Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen
|
|
EP3342779A1
(en)
|
2016-12-27 |
2018-07-04 |
Zedira GmbH |
Inhibitors of transglutaminases
|
|
US20180289676A1
(en)
|
2017-03-30 |
2018-10-11 |
Saint Louis University |
Compounds and methods targeting gper in cancer
|
|
CN108690043B
(zh)
|
2017-04-11 |
2019-10-18 |
东莞东阳光科研发有限公司 |
喹啉类衍生物及其制备方法和用途
|
|
KR102638253B1
(ko)
|
2017-05-31 |
2024-02-16 |
케모센트릭스, 인크. |
C5a 억제제로서의 6-5 융합 고리
|
|
EP3642187A1
(en)
|
2017-06-19 |
2020-04-29 |
Basf Se |
2-[[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]aryloxy](thio)acetamides for combating phytopathogenic fungi
|
|
JP2020152641A
(ja)
|
2017-07-07 |
2020-09-24 |
国立研究開発法人理化学研究所 |
リジン特異的脱メチル化酵素１阻害活性を有する新規化合物、その製造方法及びその用途
|
|
AU2018344883B2
(en)
|
2017-10-02 |
2024-03-07 |
Scientist Of Fortune S.A. |
Cellular transport system for transferring a sulfonic acid construct carrying a cargo into the cytoplasm of a cell
|
|
US10807951B2
(en)
|
2017-10-13 |
2020-10-20 |
The Regents Of The University Of California |
mTORC1 modulators
|
|
WO2019086474A1
(en)
|
2017-10-31 |
2019-05-09 |
Syngenta Participations Ag |
Pesticidally active mesoionics heterocyclic compounds
|
|
US12275729B2
(en)
|
2017-11-01 |
2025-04-15 |
Merck Sharp & Dohme Llc |
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
|
|
WO2019104070A1
(en)
|
2017-11-21 |
2019-05-31 |
Nanostring Technologies, Inc. |
O-nitrobenzyl photocleavable bifunctional linker
|
|
US20200305429A1
(en)
|
2017-11-23 |
2020-10-01 |
Basf Se |
Herbicidal phenylethers
|
|
CN111902386A
(zh)
|
2017-12-28 |
2020-11-06 |
瑞璞鑫(苏州)生物科技有限公司 |
作为fto抑制剂的苯基甲酮衍生物
|
|
CN109988109B
(zh)
|
2017-12-29 |
2020-12-29 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其用途
|
|
GB201801355D0
(en)
|
2018-01-26 |
2018-03-14 |
Enterprise Therapeutics Ltd |
Compounds
|
|
US11884645B2
(en)
|
2018-03-02 |
2024-01-30 |
Inflazome Limited |
Sulfonyl acetamides as NLRP3 inhibitors
|
|
US20190282703A1
(en)
|
2018-03-13 |
2019-09-19 |
Mavupharma, Inc. |
Ectonucleotide pyrophosphatase-phosphodiesterase (enpp) conjugates and uses thereof
|
|
WO2019191504A1
(en)
|
2018-03-30 |
2019-10-03 |
Mavupharma, Inc. |
Ectonucleotide pyrophosphate-phosphodiesterase (enpp) conjugates and uses thereof
|
|
WO2019201432A1
(en)
|
2018-04-17 |
2019-10-24 |
Zedira Gmbh |
Inhibitors of blood coagulation factor xiii
|
|
EP3781567B1
(en)
|
2018-04-20 |
2022-08-24 |
Virginia Tech Intellectual Properties, Inc. |
Imidazopyridines useful as mitochondrial uncouplers
|
|
CN110054596B
(zh)
|
2018-05-29 |
2023-03-31 |
沈阳化工大学 |
一种取代噁二唑类化合物及其应用
|
|
WO2019232245A1
(en)
|
2018-06-01 |
2019-12-05 |
The Regents Of The University Of California |
A method for fluorinated ring-opening of a substrate
|
|
EP3820500A4
(en)
|
2018-07-13 |
2022-04-13 |
Teqla Therapeutics, Inc. |
USE OF BCL6 INHIBITORS TO TREAT AUTOIMMUNE DISEASES
|
|
RU2761824C2
(ru)
|
2018-08-03 |
2021-12-13 |
Закрытое Акционерное Общество "Биокад" |
Ингибиторы CDK8/19
|
|
CN110818691A
(zh)
|
2018-08-09 |
2020-02-21 |
中国科学院上海药物研究所 |
酮酰胺类化合物及其制备方法、药物组合物和用途
|
|
US11884685B2
(en)
|
2018-08-16 |
2024-01-30 |
Cornell University |
Rhenium complexes and methods of use for treating cancer
|
|
EP3843846A4
(en)
|
2018-08-27 |
2022-09-07 |
Spinogenix, Inc. |
FASCIN-BINDING COMPOUNDS FOR SPINOGENESIS
|
|
SG11202105256QA
(en)
|
2018-11-21 |
2021-06-29 |
Accutar Biotechnology Inc |
Novel compounds having estrogen receptor alpha degradation activity and uses thereof
|
|
EP3656762A1
(en)
|
2018-11-26 |
2020-05-27 |
Instituto Biomar S.A. |
Compounds for the treatment of nf-kb-related diseases or disorders
|
|
SG11202105685TA
(en)
|
2019-01-03 |
2021-06-29 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Methods and materials for increasing transcription factor eb polypeptide levels
|
|
TWI756636B
(zh)
|
2019-02-18 |
2022-03-01 |
美商建南德克公司 |
嘧啶并嘧啶化合物及使用方法
|
|
WO2020169682A1
(en)
|
2019-02-19 |
2020-08-27 |
Yncrea Hauts De France |
Hydrazide derivatives and their specific use as antibacterial agents by controlling acinetobacter baumannii bacterium
|
|
CN110105348A
(zh)
|
2019-03-08 |
2019-08-09 |
南开大学 |
新型迈克尔受体类肠病毒71型抑制剂的制备及用途
|
|
KR20210145773A
(ko)
|
2019-03-28 |
2021-12-02 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
티에노헤테로고리형 유도체, 이의 제조 방법 및 이의 의약적 용도
|
|
AU2020289560A1
(en)
|
2019-06-05 |
2021-12-23 |
Emory University |
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
|
KR20220151038A
(ko)
*
|
2020-03-31 |
2022-11-11 |
피닉스 바이오테크놀러지 인코포레이티드. |
코로나바이러스 감염 예방를 위한 조성물
|
|
MX2021013934A
(es)
*
|
2020-04-05 |
2021-12-15 |
Pfizer |
Compuestos y metodos para el tratamiento de covid-19.
|
|
IL297069A
(en)
*
|
2020-04-10 |
2022-12-01 |
Cocrystal Pharma Inc |
Replication inhibitors of norovirus and corona virus
|
|
US11124497B1
(en)
|
2020-04-17 |
2021-09-21 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
US11174231B1
(en)
|
2020-06-09 |
2021-11-16 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
GB2595975B
(en)
|
2020-06-09 |
2022-12-07 |
Pardes Biosciences Inc |
Inhibitors of cysteine proteases and methods of use thereof
|
|
BR112022025037A2
(pt)
|
2020-06-10 |
2023-02-14 |
Aligos Therapeutics Inc |
Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus
|
|
EP4635972A3
(en)
|
2020-07-20 |
2025-12-24 |
Enanta Pharmaceuticals, Inc. |
Functionalized peptides as antiviral agents
|